Maarten Wiegerinck

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 3

Top Topics

Randomized Controlled Trial

Endothelial Cells

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Willem de Laat, Lisa Pagan, Robert Karl Malcolm, Maarten Wiegerinck, Victor Nickolson, Bertine W Huisman, Frederik E Stuurman, Michiel Joost van Esdonk, Naomi Klarenbeek
First-in-human study to assess the pharmacokinetics, tolerability, and safety of single-dose oxybutynin hydrochloride administered via a microprocessor-controlled intravaginal ring. Drug delivery 30 (1) (2023)
Willem de Laat, Lisa Pagan, Robert Karl Malcolm, Maarten Wiegerinck, Victor Nickolson, Bertine W Huisman, Frederik E Stuurman, Michiel Joost van Esdonk, Naomi Klarenbeek
First-in-human study to assess the pharmacokinetics, tolerability, and safety of single-dose oxybutynin hydrochloride administered via a microprocessor-controlled intravaginal ring. Drug delivery 30 (1) (2023)
Willem de Laat, Lisa Pagan, Robert Karl Malcolm, Maarten Wiegerinck, Victor Nickolson, Bertine W Huisman, Frederik E Stuurman, Michiel Joost van Esdonk, Naomi Klarenbeek
First-in-human study to assess the pharmacokinetics, tolerability, and safety of single-dose oxybutynin hydrochloride administered via a microprocessor-controlled intravaginal ring. Drug delivery 30 (1) (2023)